CMKLR1 and colorectal carcinoma: Experimental activation of CMKLR1 with the chemerin analog CG34 enhanced colony formation, vascularization, and tumor growth in CRC models [18], while genetic and epigenetic analyses identified chemerin-associated regulatory loci within known CRC susceptibility regions [108].